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Abstract
Background: Many adult patients with secundum-type atrial septal defects (ASDs) are able to have these defects fixed 
percutaneously. Traditionally, this has involved an assessment of ASD size, geometry and atrial septal margins by 
transoesophageal echocardiography (TOE) prior to percutaneous closure. This is a semi-invasive technique, and all of 
the information obtained could potentially be obtained by non-invasive cardiovascular magnetic resonance (CMR). We 
compared the assessment of ASDs in consecutive patients being considered for percutaneous ASD closure using CMR 
and TOE.
Methods: Consecutive patients with ASDs diagnosed on transthoracic echocardiography (TTE) were invited to 
undergo both CMR and TOE. Assessment of atrial septal margins, maximal and minimal defect dimensions was 
performed with both techniques. Analyses between CMR and TOE were made using simple linear regression and Bland 
Altman Analyses.
Results: Total CMR scan time was 20 minutes, and comparable to the TOE examination time. A total of 20 patients (M:F 
= 5:15, mean age 42.8 years ± 15.7) were included in the analyses. There was an excellent agreement between CMR 
and TOE for estimation of maximum defect size (R = 0.87). The anterior inferior, anterior superior and posterior inferior 
margins could be assessed in all patients with CMR. The posterior superior margin could not be assessed in only one 
patient. Furthermore, in 1 patient in whom TOE was unable to be performed, CMR was used to successfully direct 
percutaneous ASD closure.
Conclusions: CMR agrees with TOE assessment of ASDs in the work-up for percutaneous closure. Potentially CMR 
could be used instead of TOE for this purpose.
Background
Atrial septal defects are the most common congenital
cardiac malformation first diagnosed in adults and
account for approximately 10% of all congenital heart
lesions [1]. Patients with a significant shunt (Qp/Qs > 1.5/
1.0) experience symptoms over time with effort dyspnoea
seen in about 30% of patients by the third decade and in
over 75% of patients by the 5th decade. Complications
may include the development of pulmonary hyperten-
sion, supraventricular arrhythmias (atrial fibrillation and
atrial flutter) and right-sided heart failure from right ven-
tricular volume overload.
Surgical closure of atrial septal defects (ASDs) has pre-
viously been shown to have excellent results in both
medium and long term studies [2], but is associated with
significant morbidity and mortality [3]. Many adults with
secundum ASDs are now able to have these defects
closed percutaneously using septal occluder devices such
as the Amplatzer Septal Occluder (ASO), a self-expand-
ing circular double disc with a conjoint waist containing
polytetrafluoroethylene (PTFE) and a nitinol mesh. This
device has now become an accepted alternative to surgi-
cal repair with studies comparing ASO device closure to
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Page 2 of 6surgical closure showing decreased complication rates,
shorter hospital stays and greater cost-effectiveness [4].
The echocardiographic morphology of the ASD and
accurate assessment of the stretched diameter has been
important for patient selection. Initially, it was felt that
atrial septal defects up to 26 mm stretched balloon diam-
eter could be closed with the ASO [5]. More recently,
there is registry data of larger ASDs closed successfully
using the 40 mm ASO [6]. Inclusion criteria for percuta-
neous ASD closure have included: 1) the presence of a
secundum ASD <40 mm by echocardiography, 2) a left-
to-right shunt with a Qp/Qs ratio of >1.5:1 or the pres-
ence of right ventricular volume overload 3) patients with
minimal shunt in the presence of symptoms and 4) the
presence of a distance of >5 mm from the margins of the
ASD to the coronary sinus, atrioventricular valves and
right upper pulmonary vein as measured by echocardiog-
raphy [7-9]. Traditionally, these assessments of ASD size,
geometry and atrial septal margins have been obtained by
transoesophageal echocardiography (TOE) prior to the
percutaneous closure [7,10]. This is a semi-invasive tech-
nique and all of the information could potentially be
obtained by non-invasive cardiovascular magnetic reso-
nance (CMR). Furthermore, TOE is imperfect at assess-
ing all atrial septal margins. A large atrial septal defect
that is located inferoposteriorly is difficult to both assess
and close [7] and relates to the limited assessment of the
posterior inferior margin by TOE [11]. Although 3-D
TOE may improve this, this new technology is not yet
widely available, and yet to be shown to be superior to 2-
D TOE for this purpose.
The aim of this study was to compare the assessment of
atrial septal defects in consecutive adult patients being




Consecutive patients with secundum atrial septal defects
diagnosed on transthoracic echocardiography (TTE)
were invited to undergo both transoesophageal echocar-
diography (TOE) and CMR.
Transoesophageal echocardiographic imaging
TOE was performed with a Sonos 5500 (Phillips) TOE
system with a multiplanar 7.0mHz phased-array trans-
ducer. Cross-sectional studies of the atrial septum were
performed utilising multi-plane views as previously
described: mid-oesophageal 4-chamber views, short axis
view and biatrial long axis views [7].
Cardiovascular Magnetic Resonance
CMR studies were performed with subjects in the supine
position using a 1.5 Tesla scanner (Siemens Sonata, Ger-
many) and a phased array surface coil. Images were
obtained during end-expiratory breath-hold (8 to 10 sec-
onds) with retrospectively cardiac-gated True FISP (Fast
imaging with steady-state free precession) sequences.
Both short (modified bi-atrial) and long axis images (4
chamber views) were obtained through the ASD, with
section thickness of 6 mm and no intersection gap. Thus,
consecutive slices were obtained to cover the whole of the
interatrial septum in both short and long axis views.
Assessment of atrial septal margins, maximal and mini-
mal defect dimensions in both short and long axis views
was performed.
Measurement of atrial septal margins and defect size
TOE and CMR scans were reviewed retrospectively and 2
independent observers performed the measurements.
Images were reviewed for (a) assessibility of defect size
and septal margins by TOE, and (b) assessibility of defect
size and septal margins by CMR, (c) Agreement of the
measurements between TOE and CMR. The maximal
diameters of the atrial septal defects were measured on
both TOE and CMR. Atrial septal margins were mea-
sured as previously published [11,12]. The anterior infe-
rior (AI) rim was measured from the defect to the mitral
valve, the anterior superior (AS) rim from the defect to
the aortic root, posterior inferior (PI) rim from the defect
to the inferior vena cava and posterior superior (PS) rim
from the defect to the superior vena cava (see Figure 1).
Figure 1 Atrial septal defect (ASD) and margins imaged with CMR 
(panel A - 4 chamber view, panel B - modified biatrial short axis 
view) and transoesophageal echocardiography (panel C - 4 
chamber view, panel D - biatrial short axis view). Margins are de-
noted with AS anterior superior rim, AI anterior inferior, PS posterior su-
perior, PI posterior inferior.
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mid-oesophageal four-chamber view for AI rim, basal
short axis view for AS rim and biatrial views for PI and PS
rims. Corresponding CMR views were the four-chamber
view for AI rim, short axis view through the aorta for the
AS rim and modified biatrial short axis views for PS and
PI measurements. The size of the device occluder device
used was also compared to the maximal defect size on
CMR and TOE in patients who subsequently underwent
ASD closure.
ASD device implantation
All implantation of the ASD devices with the Amplatzer
Septal occluder were performed with TOE guidance and
fluoroscopy. A sizing balloon was used to determine the
stretched diameter of the ASD before selection and
deployment of ASO device, as previously described [8].
In brief, a Meditech balloon (Boston Scientific, Water-
town, MA) sized 20 or 27 mm was used in this series.
This balloon was inflated within the left atrium and firm
continuous pressure applied to pull it into the atrial sep-
tum, using TOE guidance. The diameter at which the bal-
loon just gets through the atrial septal defect was the
stretched balloon diameter (SBD).
Statistical Analysis
Data is presented as mean ± standard deviation. Analyses
between TOE and CMR were made using simple linear
regression analysis (SPSS 11.0 software) and Bland Alt-
man analysis [13]. Statistical significance was taken at a p
value of 0.05.
Results
A total of 20 patients (M: F = 5: 15, mean age 42.8 years ±
15.7) were included in the analyses. All but 1 patient had
both TOE and CMR to evaluate their suitability for per-
cutaneous ASD closure. TOE was not performed in 1
patient due to history of an oesophageal stricture. CMR
was well tolerated in all patients. Total CMR examination
time was 20 to 30 minutes in all cases. Three patients
were found not to be suitable for percutaneous ASD clo-
sure due to excessive stretched balloon diameter (SBD) of
>40 mm at cardiac catheterisation (CMR diameters pre-
balloon sizing were 32, 38 and 33 mm). All 3 patients
went on to surgical closure.
Assessibility of defect and margins with TOE
The maximal defect size could be assessed in all patients
(n = 19) with TOE. The anterior inferior (AI) margin,
which was measured from the defect to the mitral valve
in the mid-oesophageal 4-chamber view could be
assessed in all patients. The anterior superior margin was
assessable in 79%, the posterior inferior margin in 63%
and the posterior superior margin in 74% of patients (See
Table 1).
Assessibility of defect and margins with CMR
The maximal defect size could be assessed in all patients
(n = 20) with CMR. The anterior inferior, anterior supe-
rior and posterior inferior margins could be assessed in
all patients. The posterior superior margin could not be
assessed in only one patient.
Agreement between TOE and CMR
There was a good agreement between CMR and TOE for
estimation of maximum defect size (R = 0.87) and mini-
mum defect size (0.92). There was similar agreement
between CMR and TOE versus size of the ASO device
(Maximum defect size by CMR vs. ASO size, R = 0.53 and
maximum defect size by TOE vs. ASO size R = 0.57). See
Table 2.
Bland and Altman analyses comparing CMR and TOE
measurements of defect size and atrial septal margins are
shown in Figures 2A to E and are presented as mean of
the 2 measurements obtained by CMR and TOE ± differ-
ence between the 2 measurements.
Discussion
Many adults with secundum atrial septal defects are now
able to have these defects closed percutaneously. The
size, location and margins of an atrial septal defect are
major determining factors for transcatheter closure. Con-
ventional assessment pre-closure have been with transoe-
sophageal echocardiography (TOE) for measurement of
ASD dimensions and margins[7,10]. Inclusion criteria for
closure have included ASD maximum diameter of 40 mm
and rims of at least 5 mm towards the IVC, SVC, right
upper pulmonary vein and mitral valve [8,9]. However,
more recently, deficiency of the margins has still allowed
closure. For example, in patients with a deficient anterior
superior (AS) margin, a correctly sized Amplatzer septal
occluder can successfully be used with the device mould-
ing itself around the aortic wall with minimal risk of per-
foration [8,9]. There have also been small numbers of
patients with small inferior and posterior defect margins
(<5 mm) who have been successfully closed [9].
While TOE has been the traditional method for the
evaluation and screening for patients who are candidates
for transcatheter closure, it is semi-invasive and cannot
easily be performed in young children and some adults.
Measurements of the ASD can only be obtained from the
4-chamber, short axis and bicaval views on TOE due to
the plane on TOE that generally projects the ASD in a rel-
atively fixed direction [11]. In addition, TOE may under-
estimate the size of the stretched balloon diameter of the
ASD, although this has been described to factors associ-
ated with choice of plane for maximal diameter in defects
that are oval rather than circular in shape, displacement
of the interatrial septum from enlarged right atrium and
changes of the shape of the defect during the cardiac
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obtained from TOE images may provide superior ana-
tomic detail [10,15], but the accuracy of the recon-
structed images is dependent on technical experience of
the operator [8].
CMR has been shown to visualise secundum ASDs [16].
Studies comparing CMR with TOE to assess ASD and
suitability for percutaneous closure have mainly been
done in paediatric populations [11], although there are a
limited number of studies with adult patients [17-19]
In this study, we were able to assess maximal atrial
defect size in all patients with both TOE and CMR. In the
assessment of atrial septal margins, CMR could assess the
posterior inferior margins in all patients compared to
approximately 60% that could be assessed with TOE. One
study in a paediatric population comparing TOE and
MRI assessment showed that patients who had successful
closure had a significantly smaller major axis of ASD and
larger posterior inferior rim compared to those who were
excluded from closure procedure. An adequate posterior
inferior rim was also best visualised in that study with
CMR and showed a better correlation of ASD diameter
measurement to balloon sizing compared to TOE [11].
However, a limitation in our study of the measurement of
margins using TOE relates to this study being a retro-
spective study and with the images that were strictly
required for measurement of the margins (such as the PI
margin) not being available in some patients. Hence the
60% assessibility for the PI margin is not a true reflection
of the ability of TOE to define this margin.
In the patients (n = 3) that went on to surgical closure
of their defects, although the pre-procedure ASD diame-
ters on CMR were less than 40 mm (between 32-38 mm
in fact), the stretched balloon diameters were >40 mm,
which is beyond the largest ASD amplatzer closure
devices available, at the time of invasive assessment.
Table 1: Assessment of atrial septal defect size and margins (CMR vs. TOE)
Able to be assessed by CMR (%) Able to be assessed by TOE (%)
Maximal defect size (20/20) 100% (19/19) 100%
Anterior superior margin (20/20) 100% (15/19) 79%
Anterior inferior margin (20/20) 100% (17/19) 89%
Posterior superior margin (19/20) 95% (14/19) 74%
Posterior inferior margin (20/20) 100% (12/19) 63%
Table 2: Maximal ASD diameters and Amplatzer septal occluder size
Patient Maximal MRI Diameter (mm) Maximal TOE Diameter 
(mm)
ASO Size (mm)
1 19.7 16 26
2 11.8 11 18
3 25.2 21 32
4 17.9 21 32
5 19.1 23 20
6 15.1 14 18
7 12.7 14 24
8 25.9 35 38
9 19.2 18 26
10 15.7 12 20
11 11.4 10 16
12 15.9 19 30
13 20 21 26
14 24.2 Not Performed 30
15 23.6 22 28
16 25 27 28
17 9.2 10 20
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Figure 2 Bland Altman comparative analyses of the mean ASD dimensions and difference in dimensions between CMR and TOE. (A) Maxi-
mum defect size, (B) Anterior inferior (AI) margins, (C) Anterior superior (AS) margins, (D) Posterior inferior (PI) margins, and (E) Posterior superior (PS) 
margins.
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formed in this study, however, this is another CMR tech-
nique that can provide information about the size and
shape of the atrial septal defect [16,18] as well as provide
accurate assessment of shunt magnitude from measuring
flow in the systemic and pulmonary circulations [20,21].
However, this technique has not been used for the assess-
ment of margins due to its limited spatial resolution.
Conclusions
CMR agrees closely with TOE assessment of atrial septal
defects for percutaneous closure. In addition, it is able to
assess the septal margins such as the posterior inferior
margin, which is known to be difficult to assess with
TOE. Potentially, CMR could be used instead of TOE for
the assessment for percutaneous closure.
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